DSPE-mPEG 2000 Excipient Supplier in India: Complete Sourcing Guide

04-08-2026

DSPE-mPEG 2000 is a PEGylated phospholipid excipient used to build long circulating, sterically stabilized liposomes and lipid nanoparticles for injectable drug delivery. It combines a lipid anchor with a polyethylene glycol chain to create the so called stealth effect that keeps nanoparticles in circulation longer and reduces immune clearance. For Indian formulators working on liposomal oncology drugs, nanoparticle carriers, or advanced parenteral delivery systems, sourcing a well characterized, batch consistent DSPE-mPEG 2000 is one of the more technically demanding excipient decisions in the entire formulation.

What Is DSPE-mPEG 2000?

The full chemical name is 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000], commonly abbreviated as DSPE-mPEG 2000 or mPEG 2000-DSPE. It is typically supplied as a sodium salt, with a molecular weight in the region of 2,800 g/mol depending on the exact PEG chain distribution.

Structurally, the molecule has two parts:

DSPE, a fully saturated distearoyl phosphatidylethanolamine lipid tail that anchors into the liposomal or lipid nanoparticle bilayer.
mPEG 2000, a methoxy terminated polyethylene glycol chain with an average molecular weight of 2,000 Daltons, which projects outward from the lipid surface into the aqueous environment.

This amphiphilic structure is what allows DSPE-mPEG 2000 to sit at the lipid-water interface and form a protective PEG brush layer, commonly referred to as steric stabilization, around the nanoparticle.

Why DSPE-mPEG 2000 Is Used in Drug Delivery

Stealth liposome technology

DSPE-mPEG 2000 is the excipient behind so called stealth liposomes, most famously used in liposomal doxorubicin formulations for cancer therapy. The PEG coating reduces recognition and uptake by the reticuloendothelial system, extending circulation half life significantly compared to non-PEGylated liposomes.

Reduced aggregation and immunogenicity

By shielding the lipid surface, DSPE-mPEG 2000 minimizes particle aggregation in biological fluids and lowers the immunogenic response that can otherwise be triggered by bare lipid surfaces.

Structural role in lipid nanoparticles

Beyond classic liposomes, PEGylated lipids like DSPE-mPEG 2000 are also used as a minor structural component in some lipid nanoparticle formulations, helping control particle size and preventing premature aggregation during manufacturing and storage, although newer generation LNP platforms for nucleic acid delivery often favor shorter chain PEG lipids for faster in vivo dissociation.

Surface functionalization

DSPE-PEG derivatives with reactive end groups, such as maleimide, amine, or NHS ester terminated versions, are used to attach targeting ligands, antibodies, or other functional molecules to the nanoparticle surface, extending DSPE-mPEG chemistry into targeted drug delivery research.

Purity, Polydispersity, and Why They Matter

One of the most important and most overlooked aspects of sourcing DSPE-mPEG 2000 is polymer chain length polydispersity. Because mPEG 2000 is a polymer, not a single defined molecule, different manufacturing batches and different vendors can show meaningful variation in average chain length distribution even when both are labeled as PEG 2000.

Independent characterization work comparing DSPE-mPEG raw material from multiple vendors at declared purities ranging from roughly 90 to above 99 percent has shown real differences in impurity profiles and PEG chain length distribution between suppliers. For a formulator, this matters because polydispersity can influence particle size, surface density of PEG chains, in vivo circulation time, and ultimately batch to batch reproducibility of the finished liposomal product.

Before finalizing a supplier, request the following data points:

Declared PEG purity percentage, typically in the 90 to 99+ percent range
Analytical method used for characterization, ideally LC or GPC based methods capable of resolving chain length distribution, not just basic HPLC purity
Residual free PEG and free lipid content, since unconjugated starting materials can behave differently in the finished formulation
Sodium salt form confirmation and counter-ion content
Endotoxin data, since this excipient is almost always used in parenteral applications
Storage stability data, as PEGylated lipids are sensitive to oxidation and hydrolysis over time

DSPE-mPEG 2000 vs Other PEGylated Lipids

Formulators sometimes compare DSPE-mPEG 2000 against newer PEG lipid alternatives before finalizing a formulation strategy.

DSPE-mPEG 2000 remains the reference standard for long circulating liposomal drug products and is backed by the longest track record of approved commercial use.
DMG-PEG 2000, a shorter chain, fully synthetic PEGylated lipid, dissociates from lipid nanoparticles far more quickly in vivo, which is preferred in some nucleic acid delivery platforms where rapid PEG shedding supports faster cellular uptake and gene silencing.
Functionalized DSPE-PEG derivatives with higher PEG molecular weights, such as PEG 3400 or PEG 5000, are used in specialized targeting or bioconjugation work rather than standard stealth liposome applications.

The right choice depends entirely on whether the goal is extended systemic circulation, as with classic liposomal chemotherapy, or rapid PEG shedding for intracellular delivery, as with many nucleic acid based therapeutics.

Sourcing DSPE-mPEG 2000 in India

Because DSPE-mPEG 2000 sits at the intersection of lipid chemistry and polymer chemistry, very few manufacturers globally produce it at true pharmaceutical grade with full regulatory documentation, and pricing reflects that specialization, typically sitting well above standard phospholipid excipients on a per gram basis. In India, sourcing options generally fall into two categories: distributors representing established international lipid excipient producers, and a growing number of specialty fine chemical and biotech reagent suppliers offering research grade material for early formulation work.

For any liposomal or lipid nanoparticle project intended for clinical development, it is worth explicitly confirming whether the supplier can provide GMP grade material with a drug master file or equivalent regulatory support, since research grade PEGylated lipids are not automatically suitable for use in clinical or commercial batches.

Sourcing Through Clyzo

Formulators in India exploring specialty phospholipid and PEGylated lipid excipients, including DSPE-mPEG 2000, can check availability through Clyzo, a digital pharmaceutical excipient procurement platform based in Thane, Maharashtra. Clyzo's catalog spans thousands of pharmacopoeial and specialty excipients, and its online interface allows formulators to search for a specific grade, request samples, and review documentation before committing to a larger order, which is especially useful for a high value, specification sensitive excipient like this one.

Frequently Asked Questions

1. What is DSPE-mPEG 2000 used for?

DSPE-mPEG 2000 is used to create sterically stabilized, long circulating liposomes and lipid nanoparticles for injectable drug delivery, most notably in liposomal chemotherapy formulations.

2. What does the 2000 in DSPE-mPEG 2000 refer to?

The number refers to the average molecular weight, in Daltons, of the methoxy polyethylene glycol chain attached to the DSPE lipid anchor.

3. Why does PEG chain polydispersity matter for this excipient?

Because mPEG is a polymer rather than a single molecule, variation in chain length distribution between batches or suppliers can affect particle size, surface PEG density, and in vivo circulation behavior, so requesting chain length characterization data is important.

4. Is DSPE-mPEG 2000 the same as DSPE-PEG 2000?

Yes, these terms are generally used interchangeably in the literature and in supplier catalogs, both referring to the same methoxy-PEG-2000 conjugated DSPE lipid.

5. Can DSPE-mPEG 2000 be used in mRNA lipid nanoparticle formulations?

It can be used as a structural PEG lipid component, though many current generation nucleic acid LNP platforms favor shorter chain, more rapidly dissociating PEG lipids such as DMG-PEG 2000 for faster in vivo PEG shedding.

6. What purity level should I look for in a pharmaceutical grade supplier?

Most pharmaceutical and research grade DSPE-mPEG 2000 is offered in the 90 to above 99 percent purity range, and the exact requirement depends on whether the material is intended for early research or clinical development.

7. Is DSPE-mPEG 2000 suitable for parenteral use?

Yes, provided it is manufactured to appropriate parenteral quality standards with documented low endotoxin levels and complete batch documentation, since this excipient is almost exclusively used in injectable formulations.

8. Where can I source DSPE-mPEG 2000 in India?

Formulators can source it through distributors representing international lipid excipient manufacturers or through digital procurement platforms such as Clyzo, though it is important to confirm whether the material offered is research grade or true GMP pharmaceutical grade before use in clinical development.

Final Thoughts

DSPE-mPEG 2000 is a highly specialized excipient where the details, particularly PEG chain length consistency and documented purity, matter far more than they do for conventional phospholipids. Formulators working with this excipient in India should prioritize suppliers who can provide detailed analytical characterization and, where clinical development is the goal, genuine GMP grade material rather than research grade product alone.

Biopharma Excipients Excipient Suppliers India Injectable Excipients Lipid Nanoparticles Pharmaceutical Grade Pharmaceutical Manufacturing Protein Stabilization Regulatory Compliance USP Grade Vaccine Excipients Liposome Formulation Lipid Excipients

Vaccine Excipients Oral Topical Biopharma

Ethanol 96% v/v for pharmaceutical excipients (Ph.... ... Ethanol 96% v/v for pharmaceutical excipients (Ph.Eur., BP, USP IPEC Grade) | Clyzo Read more

14-08-2026